|
D.T. Dicheva
WHAT DIFFICULTIES DOES PRACTITIONER FACE IN TREATMENT OF IRRITABLE BOWEL SYNDROME: CLINICAL OBSERVATION
|
№s3 / 2018
|
|
E.V. Borodulina, I.V. Mareyev, M.Yu. Kolokoltsova, I.A. Samykina, V.V. Udut
COMPARATIVE EFFICIENCY OF NEOBUTINE® RETARD, FILM-COATED PROLONGED-RELEASE TABLETS 300 MG, AND TRIMEDAT®, TABLETS 200MG, IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
|
№s5-17 / 2017
|
|
I.V. Maev, A.A. Samsonov, A.V. Semenova (Yashina), D.N. Andreev, A.G. Akselrod
NEW APPROACH TO THE PAIN RELIEF IN IRRITABLE BOWEL SYNDROME
|
№6 / 2017
|
|
N.A. Agafonova, E.P. Yakovenko, A.N. Ivanov, A.V. Yakovenko
COMPREHENSIVE APPROACH TO THE THERAPY OF IRRITABLE BOWEL SYNDROME
|
№2 / 2017
|
|
E.P. Yakovenko, N.A. Agafonova, A.N. Ivanov, A.V. Yakovenko, E.V. Anikina
ABDOMINAL PAIN: FROM PATHOGENESIS TO TREATMENT
|
№2 / 2015
|
|
E.A. Kornienko, M.Yu. Tipikina
RESULTS OF EVALUATION OF THE EFFICACY OF PROBIOTICS AND CORRECTION OF BOWEL MOTILITY IN IBS IN CHILDREN
|
№2 / 2014
|
|
Belousova E.A., Bulgakov S.A.
Medicinal Agents - Opiate Receptors Ligands And Their Use In Gastroenterology
|
№2 / 2011
|
|
E. A. Belousova
Idiopathic Slow-transit Constipation: Mechanisms Of Development And Treatment Potentials
|
№15 / 2010
|
Русский
